Abstract
Objectives To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have